Detalhe da pesquisa
1.
Assessment of SARS-CoV-2 entry in gingival epithelial cells expressing CD147.
Eur J Oral Sci
; 131(1): e12906, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36412995
2.
Inhibition of SARS-CoV-2 infection by Porphyromonas gingivalis and the oral microbiome.
bioRxiv
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464164
3.
Robust immune response elicited by a novel and unique Mycobacterium tuberculosis protein using an optimized DNA/protein heterologous prime/boost protocol.
Immunology
; 135(3): 216-25, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22043824
4.
Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses.
J Virol
; 83(11): 5505-13, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19297477
5.
A Systematic Approach to HIV-1 Vaccine Immunogen Selection.
AIDS Res Hum Retroviruses
; 36(9): 762-770, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32056466
6.
The impact of a boosting immunogen on the differentiation of secondary memory CD8+ T cells.
J Virol
; 81(23): 12793-802, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17881444
7.
Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.
PLoS One
; 10(11): e0143422, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26618634
8.
Commensal Streptococcus mitis is a unique vector for oral mucosal vaccination.
Microbes Infect
; 17(3): 237-42, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25522856
9.
An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection.
Vaccine
; 31(42): 4834-40, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23933335
10.
Current and novel approaches to vaccine development against tuberculosis.
Front Cell Infect Microbiol
; 2: 154, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23230563
11.
Correction: Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.
PLoS One
; 11(1): e0147781, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26800455
12.
Effects of type I interferons on the adjuvant properties of plasmid granulocyte-macrophage colony-stimulating factor in vivo.
J Virol
; 81(19): 10606-13, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17652387
13.
Duration of antigen expression in vivo following DNA immunization modifies the magnitude, contraction, and secondary responses of CD8+ T lymphocytes.
J Immunol
; 179(10): 6725-33, 2007 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17982062
14.
Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis.
J Virol
; 81(1): 74-83, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17050608
15.
Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis.
Clin Vaccine Immunol
; 13(11): 1204-11, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16943347
16.
Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.
J Virol
; 80(4): 1645-52, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16439521